A blog about Attention Deficit Disorder, and Attention Deficit Hyperactivity Disorder

Visit ADD ADHD Blog

FDA Warns ADHD Pharmaceutical Companies

Posted on October 01, 2008

The FDA sent formal warning letters to the makers of ADHD medications for inappropriate and misleading information in their advertising. The warning applied to the makers of Strattera (Eli Lilly), Adderall XR and Vyvanse (Shire) and Concerta (Ortho-MacNeil).In summary - the concerns of the FDA were that the ads or promotional materials in question were overstating benefits and not disclosing the risks. To read more, visit CNN s article here.Share This...

Original article link


adhd , strattera